180 related articles for article (PubMed ID: 10400249)
1. Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats.
Wada Y; Hirao N; Shiraishi J; Nakamura M; Koshino Y
Neurosci Lett; 1999 May; 267(1):61-4. PubMed ID: 10400249
[TBL] [Abstract][Full Text] [Related]
2. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
Gobert A; Millan MJ
Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
[TBL] [Abstract][Full Text] [Related]
3. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
Dawson LA; Nguyen HQ
Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
[TBL] [Abstract][Full Text] [Related]
4. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
Moser PC; Sanger DJ
Eur J Pharmacol; 1999 May; 372(2):127-34. PubMed ID: 10395092
[TBL] [Abstract][Full Text] [Related]
5. Greater effects of fluoxetine and its combination with (-)-pindolol in elevating hypothalamic serotonin in rats during dark hours.
Dreshfield LJ; Rocco VP; Wong DT
Chin J Physiol; 1997 Jun; 40(2):57-61. PubMed ID: 9303241
[TBL] [Abstract][Full Text] [Related]
6. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635.
Fornal CA; Martin FJ; Metzler CW; Jacobs BL
J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908
[TBL] [Abstract][Full Text] [Related]
7. [Effect of (+/-)-pindolol on the central 5-HT1A receptor by the use of in vivo microdialysis and hippocampal slice preparations].
Tsuji K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Jun; 22(3):85-95. PubMed ID: 12166089
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors.
Dreshfield LJ; Wong DT; Perry KW; Engleman EA
Neurochem Res; 1996 May; 21(5):557-62. PubMed ID: 8726963
[TBL] [Abstract][Full Text] [Related]
9. Interaction studies of 5-HT1A receptor antagonists and selective 5-HT reuptake inhibitors in isolated aggressive mice.
Sànchez C
Eur J Pharmacol; 1997 Sep; 334(2-3):127-32. PubMed ID: 9369340
[TBL] [Abstract][Full Text] [Related]
10. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
[TBL] [Abstract][Full Text] [Related]
11. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
Béïque JC; Blier P; de Montigny C; Debonnel G
Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
[TBL] [Abstract][Full Text] [Related]
12. Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.
Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
Pol J Pharmacol; 2002; 54(6):615-23. PubMed ID: 12866716
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
Barton CL; Hutson PH
Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
[TBL] [Abstract][Full Text] [Related]
14. Synergistic neurochemical and behavioral effects of fluoxetine and 5-HT1A receptor antagonists.
Trillat AC; Malagié I; Mathe-Allainmat M; Anmella MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Sep; 357(2-3):179-84. PubMed ID: 9797034
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors.
Browning RA; Wood AV; Merrill MA; Dailey JW; Jobe PC
Eur J Pharmacol; 1997 Oct; 336(1):1-6. PubMed ID: 9384247
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of the effects of fluoxetine on serotonergic neuronal activity by pindolol in rats.
Rasmussen K; McCreary AC; Shanks EA
Neurosci Lett; 2004 Jan; 355(1-2):1-4. PubMed ID: 14729220
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine attenuates thermal hyperalgesia through 5-HT1/2 receptors in streptozotocin-induced diabetic mice.
Anjaneyulu M; Chopra K
Eur J Pharmacol; 2004 Aug; 497(3):285-92. PubMed ID: 15336946
[TBL] [Abstract][Full Text] [Related]
18. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
Hervás I; Artigas F
Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935.
Gobert A; Rivet JM; Cistarelli L; Millan MJ
J Neurochem; 1997 Mar; 68(3):1159-63. PubMed ID: 9048762
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
Dawson LA; Nguyen HQ; Smith DL; Schechter LE
J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
